GSK3B and neoplasm: The perturbation analysis also led to the novel prediction that activation of GSK3B, SMAD, ROS, PP2A, ATM, or CERAMIDE could inhibit proliferation or induce apoptosis of preneoplastic IECs in the pro-tumor inflammatory microenvironment, indicating that these molecules can be potential therapeutic targets for preventing CAC development.